AW
NVAX icon

ACG Wealth’s Novavax NVAX Stock Holding History

ACG Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,700
Closed -$190K – 756
2022
Q2 		$190K Sell
3,700
-60
-2% -$3.11K 0.04% 251
2022
Q1 		$277K Hold
3,760
– – 0.05% 230
2021
Q4 		$538K Hold
3,760
– – 0.08% 204
2021
Q3 		$779K Hold
3,760
– – 0.1% 162
2021
Q2 		$798K Hold
3,760
– – 0.1% 162
2021
Q1 		$682K Sell
3,760
-37
-1% -$7.37K 0.09% 166
2020
Q4 		$423K Buy
3,797
+35
+0.9% +$3.72K 0.06% 198
2020
Q3 		$408K Buy
3,762
+62
+2% +$7.55K 0.06% 192
2020
Q2 		$308K Buy
+3,700
New +$142K 0.05% 202

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ACG Wealth's NVAX Position: Q3 2022 in Review

ACG Wealth sold out of Novavax (NVAX) in Q3 2022, closing a stake of 3,700 shares — an estimated $190K sold.

ACG Wealth first reported a position in NVAX in Q2 2020 and held it in 9 quarters. The position peaked at $798K in Q2 2021. 253 funds tracked by Wall St. Rank hold NVAX as of Q3 2022.

  • ACG Wealth reported no remaining Novavax position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 3,700 Novavax shares in Q3 2022, an estimated $190K.
  • ACG Wealth first reported a position in Novavax in Q2 2020 and held it in 9 quarters.
  • ACG Wealth's Novavax position peaked at $798K in Q2 2021.
  • 253 funds tracked by Wall St. Rank held Novavax as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.